Erdil, NevzatEroğlu, TamerAkça, BarışDişli, Olcay MuratYetkin, ÖzkanÇolak, Mehmet CengizErdil, Feray AkgülBattaloğlu, Bektaş2017-07-152017-07-152016ERDİL, N., EROĞLU, T., AKÇA, B., DİŞLİ, O. M., YETKİN, Ö., ÇOLAK, M. C., … BATTALOĞLU, B. (2016). The effects of N acetylcysteine on pulmonary functions in patients undergoing on pump coronary artery surgery a double blind placebo controlled study. Eur Rev Med Pharmacol Sci, 0–0.http://www.europeanreview.org/wp/wp-content/uploads/180-187.pdfhttps://hdl.handle.net/11616/7398European Review for Medical and Pharmacological SciencesAbstract. – OBJECTIVE: To investigate the effects of N-acetylcysteine (NAC) on pulmonary function tests and arterial blood gases in patients undergoing on-pump coronary artery surgery. PATIENTS AND METHODS: The effect of NAC was assessed within the scope of a prospective, single center, double-blind, placebo-controlled, parallel group study. Eighty-two patients undergoing coronary artery bypass grafting were randomized into two groups to receive either placebo (group 1, n = 40) or NAC (group 2, n=42). Both the NAC group and the placebo-receiving control group also included a COPD subgroup consisting of patients with an FEV1/FVC ratio of < 0.7 and an FEV1 value of 50- 80%. Pulmonary function tests were performed preoperatively and on postoperative day 60. RESULTS: Both groups were similar with respect to age, gender, preoperative risk factors, ejection fraction (EF), mean cross-clamp time, ventilation time, intensive care unit (ICU) stay, atrial fibrillation (AF) and hospital stay (p > 0.05). Postoperative FVC and FEV1 values in group 1 and the postoperative FEV1, FEV1/FVC and FEF 25-75 values in group 2 were lower in comparison to their preoperative values. However, in both group 1 and 2, the decreases observed in these parameters were not statistically significant (p > 0.05). In the COPD subgroup of group 1, a postoperative decrease was observed in the FEV1 and FEF25-75 values, with the FEV1 decreasing by 4.55%, and the FEF25-75 decreasing by 4.2% (p < 0.05). In the COPD subgroup of group 2, no significant decrease was observed in the pulmonary function test values (p > 0.05).eninfo:eu-repo/semantics/openAccessN-AcetylcysteinePulmonary function testBypass surgeryCoronary arteryArticle0000